Results 1 to 10 of about 4,497,204 (150)

Primary idiopathic hyperaldosteronism in clinical practice [PDF]

Ожирение и метаболизм, 2012
Primary hyperaldosteronism (PHA) is a clinical syndrome that develops as a result of excess production of aldosterone by adrenal glomerular zone, where aldosterone secretion is completely or partially autonomous in relation to the renin-angiotensin ...

doaj   +2 more sources

Primary hyperaldosteronism presenting with rhabdomyolysis in emergency room – Case report

Journal of Acute Disease, 2016
Primary hyperaldosteronism, is a well-known cause of secondary hypertension, mostly idiopathic hypertension or arising from aldosterone-producing adenomas.
Ilkay Cakir, Serkan Senol, Yasin Simsek, Zuleyha Karaca, Kursad Unluhizarci, Fatih Tanrıverdi   +5 more
doaj   +2 more sources

Primary hyperaldosteronism with concomitant cortisol secretion [PDF]

Наука и инновации в медицине
Aim – to study the diagnostic possibilities of comparative selective venous blood sampling from the central adrenal vein in patients with primary hyperaldosteronism with combined autonomous cortisol secretion. Material and methods.
Aleksandr A. Lisitsyn, Vyacheslav P. Zemlyanoi, Mikhail M. Nakhumov, Zulfiya R. Shafigullina, Sergei B. Shustov, Irina A. Bekhtereva   +5 more
doaj   +3 more sources

Primary Hyperaldosteronism As A Risk Factor For Recurrent Nephrolithiasis

Kidney Research and Clinical Practice, 2012
Primary hyperaldosteronism typically presents as hypertension, hypokalemia, and metabolic alkalosis. Several previous reports note an association between primary hyperaldosteronism and nephrolithiasis with secondary hyperparathyroidism.
Ekamol Tantisattamo, Thomas B. Francis
doaj   +2 more sources

CHARACTERISTICS AND FEATURES OF CLINICAL MANIFESTATIONS OF PRIMARY HYPERALDOSTERONISM (LITERATURE REVIEW) [PDF]

Romanian Journal of Medical Practice, 2019
Introduction. Primary hyperaldosteronism as a cause of secondary arterial hypertension ranges from 4.6 to 13.0%, and among patients with refractory hypertension to medication therapy is about 20%.
Viktor O. Shidlovskyi, Olexandr V. Shidlovskyi, Michael I. Sheremet, Natalia A. Sheremet, Nina P. Tkachuk, Vitaliy V. Maksymyuk, Volodimir V. Tarabanchuk, Yan V. Gyrla, Oleksandr V. Bilookyi   +8 more
doaj   +3 more sources

Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis

Therapeutic Advances in Chronic Disease
Background: The effectiveness and side effects between different medical treatments in patients with primary hyperaldosteronism have not been systematically studied.
Wen-Yu Ho, Ching-Chung Hsiao, Ping-Hsun Wu, Jui-Yi Chen, Yu-Kang Tu, Vin-Cent Wu, Jia-Jin Chen   +6 more
doaj   +2 more sources

Primary hyperaldosteronism: indications for screening

Терапевтический архив, 2022
The review discusses the current state of the problem of screening patients for early detection of primary hyperaldosteronism (PHA) as a potential cause of arterial hypertension (AH).
Novella M. Chikhladze
doaj   +1 more source

Primary hyperaldosteronism: difficulties in diagnosis [PDF]

Терапевтический архив, 2019
Primary hyperaldosteronism (PA) - is the clinical syndrome, results from autonomous of the major regulators of secretion, aldosterone overproduction by a tumorous or hyperplastic tissue in adrenal cortex.
B M Shifman, N M Platonova, N V Molashenko, E A Troshina, I I Sitkin, D G Belcevich, L D Kovalevich, N Yu Romanova, G S Kolesnikova   +8 more
doaj   +1 more source

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism

Journal of Diabetes Investigation, 2020
Aims/Introduction An increased risk of diabetes mellitus has been reported in primary aldosteronism, but the pathogenesis of glucose intolerance between the primary aldosteronism subtypes remains unclear.
Mikiko Okazaki‐Hada, Ayako Moriya, Mototsugu Nagao, Shinichi Oikawa, Izumi Fukuda, Hitoshi Sugihara   +5 more
doaj   +1 more source

Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study

Current Issues in Molecular Biology, 2021
Primary aldosteronism is most often caused by aldosterone-producing adenoma (APA) and bi-lateral adrenal hyperplasia. Most APAs are caused by somatic mutations of various ion channels and pumps, the most common being the inward-rectifying potassium ...
Nae Takizawa, Susumu Tanaka, Koshiro Nishimoto, Yuki Sugiura, Makoto Suematsu, Chisato Ohe, Haruyuki Ohsugi, Yosuke Mizuno, Kuniaki Mukai, Tsugio Seki, Kenji Oki, Celso E. Gomez-Sanchez, Tadashi Matsuda   +12 more
doaj   +1 more source